Paclitaxel Injection (260mg)

Paclitaxel Injection (260mg) is used to treat cancer in the cervix, bladder, uterus, neck, etc. Our company is a prominent Manufacturer, Supplier and Exporter of Paclitaxel Injection (260mg) from Delhi. Paclitaxel Injection (260mg) may cause a large decrease in the number of white blood cells. We ensure that the composition of Paclitaxel Injection (260mg) is accurate and it is packaged under hygienic conditions.

Indications :

• Primary Indications :

  • Breast Cancer

  • Cervical Cancer

  • Endometrial Cancer

  • Lung Cancer

  • Kaposi's Carcoma

  • Ovarian Cancer

• Secondary Indications :

  • Bladder Cancer

  • Leukemias

  • Head & Neck Cancer

  • Malignant Melanoma

Dosage :

• Primary treatment of Ovarian Cancer : 175mg/m2 IV over a period of 3 hours, followed by Cisplatin 75mg/m2, with a 3 week interval between courses. It should be used at a dose of 135mg/m2, administered IV over 3 hours followed by Cisplatin 75mg/m2. The infusion should be repeated every 3 weeks.

• Secondary treatment of Ovarian Cancer and Breast Cancer : 175mg/m2 IV over a period of 3 hours every three weeks. Patients who experience severe neutropenia (neutrophil < 500 cells/mm3) or severe peripheral neuropathy should receive a dosage reduced by 20% for subsequent courses.

• Kaposi's sarcoma : 135mg/m2 IV over a period of 3 hours, with a 3 week interval between courses, or, 100mg/m2 IV over a period of 3 hours with a 2 week interval between courses.

• Both regimens result in comparable dosing intensity (45-50mg/m2/week).

• Primary treatment of NSCLC : 175mg/m2 IV over a period of 3 hours, followed by a platinum compound, with a 3 week interval between courses.

Dosage Adjustment :

• Renal Impairment : Not Required.

• Hepatic Impairment : Required.

Packing : 260 mg